GSE233679 nicotinamide 12 v 8 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE233679_nicotinamide_12_v_8_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE233679_nicotinamide_12_v_8_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE233679_nicotinamide_12_v_8_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE233679_nicotinamide_12_v_8_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

H19 imprinted maternally expressed transcript

Gene

FOXD3 antisense RNA 1

Gene

family with sequence similarity 225 member B

Gene

long intergenic non-protein coding RNA 2236

Gene

BBSome interacting protein 1 pseudogene 1

Gene

ribosomal protein L7a pseudogene 24

Gene

uncharacterized LOC107984273

Gene

BICD1 antisense RNA 1

Gene

microRNA 544b

Gene

RNA, 7SL, cytoplasmic 339, pseudogene

  • Gene

    H19 imprinted maternally expressed transcript


  • Gene

    FOXD3 antisense RNA 1


  • Gene

    family with sequence similarity 225 member B


  • Gene

    long intergenic non-protein coding RNA 2236


  • Gene

    BBSome interacting protein 1 pseudogene 1


  • Gene

    ribosomal protein L7a pseudogene 24


  • Gene

    uncharacterized LOC107984273


  • Gene

    BICD1 antisense RNA 1



  • Gene

    RNA, 7SL, cytoplasmic 339, pseudogene

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.